Dominique Monnet serves as Executive at ALEXION PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Dominique Monnet has executed 12 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 16, 2020 involved selling 500,000 shares valued at $1.3M.
Dominique Monnet currently holds 734,921 shares of ALEXION PHARMACEUTICALS INC (ALXN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dominique Monnet has been a net seller of ALXN stock. They have purchased $0 and sold $1.4M worth of shares.
Dominique Monnet's most recent insider trade was on Dec 16, 2020, when they sold 500,000 shares at $2.60 per share.
Get notified when new Form 4 filings are submitted
| $3.51 |
| Discretionary |
| Jan 8, 2020 | PDLI | $0 | Award | 1,233,766 | $N/A | Discretionary |
| Jan 8, 2020 | PDLI | $0 | Award | 1,233,766 | $N/A | Discretionary |
| Mar 28, 2019 | PDLI | $1.6M | Award | 431,317 | $3.72 | Discretionary |
| Mar 28, 2019 | PDLI | $1.7M | Award | 451,075 | $3.72 | Discretionary |
| Dec 27, 2018 | PDLI | $53.2K | Payment | 17,615 | $3.02 | Discretionary |
| Sep 12, 2017 | PDLI | $0 | Award | 240,200 | $N/A | Discretionary |
| May 20, 2015 | ALXN | $41.6K | Sale | 256 | $162.40 | Discretionary |
| Feb 27, 2015 | ALXN | $0 | Award | 3,830 | $N/A | Discretionary |
| Feb 10, 2015 | ALXN | $55.6K | Sale | 325 | $171.15 | Discretionary |
| Feb 5, 2015 | ALXN | $0 | Award | 2,538 | $N/A | Discretionary |